Bar, J., Sorotsky, H. G., Urban, D., Onn, A., Daher, S. N., Makarov, M., Nasrallah, H., Lawrence, Y., Kamer, I., Milov, E., Halberstam, S., Zer, A., Appel, S. (2026). Concomitant radiotherapy, tremelimumab, and durvalumab for advanced NSCLC patients progressing on first-line immunotherapy: A phase 2 study (CORAL-Lung).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.8583